 | | Vol. 6.15 – 29 April, 2022 |
| |
|
|
| The proportion of cellular polyploidy decreases during HCC progression and Anillin actin binding protein level was significantly correlated with cellular polyploidy proportion in human HCC samples.
[Oncogene] |
|
|
|
 | | PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers elucidated the modulation of IL-36R-P2X7R-TLRs axis affected hepatocytes steatosis and IL-36-based inflammatory feedback loop that accompanied the onset of alcoholic steatohepatitis.
[British Journal of Pharmacology] |
|
|
|
| MyD88 signaling in HSCs increased the secretion of CXCL10, which promoted macrophage M1 polarization through CXCR3, leading to activation of the JAK/STAT1 pathway.
[Cell Death & Disease] |
|
|
|
| Scientists investigated the effects of human bone marrow mesenchymal stem cells (hMSCs) -derived exosome circCDK13 on liver fibrosis and its mechanism.
[Cell Biology and Toxicology] |
|
|
|
| Researchers found for the first time that apigenin could alleviate palmitic acid (PA)-induced NLRP3 inflammasome activation and pyroptosis in HepG2 cells and primary mouse hepatic cells.
[Food & Function] |
|
|
|
| In this study, scientists evaluated the potential suitability of broxbam for the treatment of liver cancer.
[International Journal of Oncology] |
|
|
|
| HSC activation is a central event of hepatic fibrosis progression. In this study, the up-regulation of lncRNA ANXA2P2 was found in liver fibrosis.
[Toxicology Letters] |
|
|
|
| The effects of miR‑4730 overexpression were examined in liver cancer cell lines, and the target genes of miR‑4730 were evaluated using microarray analysis and TargetScan data.
[International Journal of Molecular Medicine] |
|
|
|
| Researchers evaluated the effect of thymoquinone on hepatotoxicity induced by iron-overload in in vitro and mouse model.
[Biological Trace Element Research] |
|  |
|
|
|
| The authors discuss the molecular pathogenesis of hepatocellular carcinoma, molecular classes and determinants of heterogeneity.
[Nature Cancer] |
|
|
|
|
| Galmed Pharmaceuticals Ltd. announced interim results from the Open-Label Part of the ARMOR study showing fibrosis improvement with Aramchol using multimodality histological assessment.
[Galmed Pharmaceuticals Ltd.] |
|
|
|
|
| May 22 – 25, 2022
Denver, Colorado, United States |
|
|
|
|
|
| National Institute for Health and Medical Research – Strasbourg, France |
|
|
|
| | Baylor College of Medicine – Houston, Texas, United States |
|
|
|
| | City of Hope – Duarte, California, United States |
|
|
|
| | Johns Hopkins University – Baltimore, Maryland, United States |
|
|
|
| | The University of British Columbia – Vancouver, British Columbia, Canada |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
